patient access

Market Access

Part Two: Navigating the complexities of global market acces...

The journey to global market access for innovative therapies is fraught with challenges that vary significantly across the world.

Market Access

Seizing the moment: The life sciences industry at the thresh...

The passage of the Inflation Reduction Act (IRA) signifies more than just a legislative milestone; it acts as a clarion call to the pharmaceutical industry.

Patients

From the Margins: Gilead book launch shines light on health ...

On Wednesday 13th September, pharmaphorum headed to London’s Wellcome Collection for Gilead’s book launch of “From the Margins”, a unique and impactful publication that brings together in o

Patients

Eliminating disruption with Eddy Effect metric elevates CX

Between ongoing drug shortages, navigating complex insurance benefits, understanding the confusing language of

Digital

Why IoMT is key to successful healthcare innovation

On the 75th anniversary of World Health Day, it’s notable that this year’s theme is about ‘health for all’.

News

J&J copay lawsuit against drug benefit firm gets green light

Johnson & Johnson has been cleared to continue a lawsuit filed last year against drug benefit programme SaveOnSP, which claims it defrauded a payment assistance programme for patients o